{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:21:35Z","timestamp":1791404495339,"version":"4.3.3"},"reference-count":46,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2000,10,20]]},"abstract":"<jats:p>PURPOSE: To evaluate the diagnostic value of positron emission tomography (PET) using fluorine-18 fluorodeoxyglucose (FDG) for the diagnosis of primary breast cancer.<\/jats:p>\n                  <jats:p>PATIENTS AND METHODS: Preoperatively, 144 patients with masses suggestive of breast cancer underwent PET imaging of the breast. To identify breast cancer by increased metabolic activity, parametric FDG-PET images were analyzed for increased tracer uptake applying conventional image reading (CIR) and sensitive image reading (SIR). One hundred eighty-five breast tumors were evaluated by histology, revealing 132 breast carcinomas and 53 benign masses.<\/jats:p>\n                  <jats:p>RESULTS: Breast carcinomas were identified with an overall sensitivity of 64.4% (CIR) and 80.3% (SIR). The increase in sensitivity (SIR) resulted in a noticeable decrease in specificity, from 94.3% (CIR) to 75.5% (SIR). At stage pT1, only 30 (68.2%) of 44 breast carcinomas were detected, compared with 57 (91.9%) of 62 at stage pT2. A higher percentage of invasive lobular carcinomas were false-negative (65.2%) compared with invasive ductal carcinomas (23.7%). Nevertheless, positive PET scans provided a high positive-predictive value (96.6%) for breast cancer.<\/jats:p>\n                  <jats:p>CONCLUSION: Partial volume effects and varying metabolic activity (dependent on tumor type) seem to represent the most significant limitations for the routine diagnostic application of PET. The number of invasive procedures is therefore unlikely to be significantly reduced by PET imaging in patients presenting with abnormal mammography. However, the high positive-predictive value, resulting from the increased metabolic activity of malignant tissue, may be used with carefully selected subsets of patients as well as to determine the extent of disease or to assess therapy response.<\/jats:p>","DOI":"10.1200\/jco.2000.18.20.3495","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T04:03:48Z","timestamp":1487909028000},"page":"3495-3502","source":"Crossref","is-referenced-by-count":474,"title":["Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations"],"prefix":"10.1200","volume":"18","author":[{"given":"N.","family":"Avril","sequence":"first","affiliation":[{"name":"From the Departments of Nuclear Medicine and Gynecology, Technische Universit\u00e4t M\u00fcnchen, Munich; and Department of Gynecology, University Hospital Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Ros\u00e9","sequence":"additional","affiliation":[{"name":"From the Departments of Nuclear Medicine and Gynecology, Technische Universit\u00e4t M\u00fcnchen, Munich; and Department of Gynecology, University Hospital Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schelling","sequence":"additional","affiliation":[{"name":"From the Departments of Nuclear Medicine and Gynecology, Technische Universit\u00e4t M\u00fcnchen, Munich; and Department of Gynecology, University Hospital Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dose","sequence":"additional","affiliation":[{"name":"From the Departments of Nuclear Medicine and Gynecology, Technische Universit\u00e4t M\u00fcnchen, Munich; and Department of Gynecology, University Hospital Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Kuhn","sequence":"additional","affiliation":[{"name":"From the Departments of Nuclear Medicine and Gynecology, Technische Universit\u00e4t M\u00fcnchen, Munich; and Department of Gynecology, University Hospital Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bense","sequence":"additional","affiliation":[{"name":"From the Departments of Nuclear Medicine and Gynecology, Technische Universit\u00e4t M\u00fcnchen, Munich; and Department of Gynecology, University Hospital Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Weber","sequence":"additional","affiliation":[{"name":"From the Departments of Nuclear Medicine and Gynecology, Technische Universit\u00e4t M\u00fcnchen, Munich; and Department of Gynecology, University Hospital Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ziegler","sequence":"additional","affiliation":[{"name":"From the Departments of Nuclear Medicine and Gynecology, Technische Universit\u00e4t M\u00fcnchen, Munich; and Department of Gynecology, University Hospital Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Graeff","sequence":"additional","affiliation":[{"name":"From the Departments of Nuclear Medicine and Gynecology, Technische Universit\u00e4t M\u00fcnchen, Munich; and Department of Gynecology, University Hospital Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schwaiger","sequence":"additional","affiliation":[{"name":"From the Departments of Nuclear Medicine and Gynecology, Technische Universit\u00e4t M\u00fcnchen, Munich; and Department of Gynecology, University Hospital Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1-0480","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209243271307"},{"key":"R2-0480","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.20.1644"},{"key":"R3-0480","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(87)90341-5"},{"key":"R4-0480","doi-asserted-by":"crossref","unstructured":"Kopans DB: Mammography screening and the controversy concerning women aged 40 to 49. Radiol Clin North Am 33: 1273,1995-1290,","DOI":"10.1016\/S0033-8389(22)00657-1"},{"key":"R5-0480","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.173.2.2678242"},{"key":"R6-0480","doi-asserted-by":"crossref","unstructured":"Kopans DB, Feig SA: False positive rate of screening mammography. N Engl J Med 339: 562,1998-564,","DOI":"10.1056\/NEJM199808203390812"},{"key":"R7-0480","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.158.3.1310825"},{"key":"R8-0480","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440170063037"},{"key":"R9-0480","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.184.3.1509041"},{"key":"R10-0480","doi-asserted-by":"crossref","unstructured":"Jackson VP: The current role of ultrasonography in breast imaging. Radiol Clin North Am 33: 305,1995-311,","DOI":"10.1016\/S0033-8389(22)00650-9"},{"key":"R11-0480","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.196.1.7784555"},{"key":"R12-0480","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.171.1.2648479"},{"key":"R13-0480","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.191.3.8184038"},{"key":"R14-0480","doi-asserted-by":"publisher","DOI":"10.1007\/s003300050463"},{"key":"R15-0480","doi-asserted-by":"publisher","DOI":"10.1007\/BF01249629"},{"key":"R16-0480","doi-asserted-by":"publisher","DOI":"10.1007\/s000660050022"},{"key":"R18-0480","doi-asserted-by":"publisher","DOI":"10.1126\/science.123.3191.309"},{"key":"R19-0480","doi-asserted-by":"crossref","unstructured":"Som P, Atkins HL, Bandoypadhay D, et al: A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic tracer for rapid tumor detection. J Nucl Med 21: 670,1980-675,","DOI":"10.1097\/00004728-198012000-00045"},{"key":"R20-0480","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.179.3.2027989"},{"key":"R21-0480","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.187.3.8497624"},{"key":"R22-0480","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.6.1848"},{"key":"R23-0480","unstructured":"Hamacher K, Coenen HH, St\u00f6cklin G: Efficient stereospecific synthesis of nocarrier-added 2-(F-18)-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27: 235,1986-238,"},{"key":"R24-0480","unstructured":"Avril N, Bense S, Ziegler SI, et al: Breast imaging with fluorine-18-FDG PET: Quantitative image analysis. J Nucl Med 38: 1186,1997-1191,"},{"key":"R26-0480","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930615)71:12<3920::AID-CNCR2820711220>3.0.CO;2-N"},{"key":"R27-0480","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199207000-00005"},{"key":"R28-0480","doi-asserted-by":"publisher","DOI":"10.1007\/BF00834522"},{"key":"R29-0480","unstructured":"Kramer S, Schulz-Wendtland R, Hagedorn K, et al: Magnetic resonance imaging and its role in the diagnosis of multicentric breast cancer. Anticancer Res 18: 2163,1998-2164,"},{"key":"R30-0480","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H"},{"key":"R31-0480","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.178.1.1984294"},{"key":"R32-0480","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.161.5.8273634"},{"key":"R33-0480","doi-asserted-by":"publisher","DOI":"10.1097\/00004424-199303000-00002"},{"key":"R34-0480","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.195.1.7892476"},{"key":"R35-0480","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005921513083"},{"key":"R36-0480","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-197906000-00001"},{"key":"R37-0480","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.207.3.9609902"},{"key":"R38-0480","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-198909000-00014"},{"key":"R39-0480","unstructured":"Lewis P, Salama A: Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 35: 1647,1994-1649,"},{"key":"R40-0480","doi-asserted-by":"crossref","unstructured":"Dowlatshahi K, Yaremko ML, Kluskens LF, et al: Nonpalpable breast lesions: Findings of stereotaxic needle-core biopsy and fine needle aspiration cytology. Radiology 185: 639,1991-640,","DOI":"10.1148\/radiology.181.3.1947091"},{"key":"R41-0480","doi-asserted-by":"publisher","DOI":"10.1016\/S1095-0397(99)00032-1"},{"key":"R42-0480","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.17.1204"},{"key":"R43-0480","unstructured":"Moon DH, Maddahi J, Silverman DH, et al: Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. J Nucl Med 39: 431,1998-435,"},{"key":"R44-0480","unstructured":"Bender H, Kirst J, Palmedo H, et al: Value of F-18 fluorodeoxyglucose positron emission tomography in the staging of recurrent breast carcinoma. Anticancer Res 17: 1687,1997-1692,"},{"key":"R45-0480","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.11.2101"},{"key":"R46-0480","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.6.1470"},{"key":"R47-0480","unstructured":"Bassa P, Kim EE, Inoue T, et al: Evaluation of preoperative chemotherapy using PET with fluorine-18- fluorodeoxyglucose in breast cancer. J Nucl Med 37: 931,1996-938,"},{"key":"R48-0480","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.8.1689"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2000.18.20.3495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T06:34:02Z","timestamp":1692686042000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2000.18.20.3495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,20]]},"references-count":46,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2000,10,20]]}},"alternative-id":["10.1200\/JCO.2000.18.20.3495"],"URL":"https:\/\/doi.org\/10.1200\/jco.2000.18.20.3495","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10,20]]}}}